Medtech M&A: McEvoy on Where Will AMO Fit into J&J and What the Deal Means for Eye Care

MT042_Podcast_Facebook

EPISODE 042

Ashley McEvoy, company group chairman, Johnson & Johnson Vision Care and Johnson & Johnson Diabetes Care Companies, says the new force could pursue M&A in future expansion. Hear the details of the deal.

Podcast Guest

Ashley McEvoy

Ashley McEvoy

Company Group Chairman

Johnson & Johnson Vision

Ashley McEvoy is Company Group Chairman for Johnson & Johnson Vision and Diabetes Care Companies, two medically directed, consumer-informed businesses within the company’s global medical device segment. The companies, best known for their market-leading ACUVUE® Brand Contact lenses and ONETOUCH® Diabetes Devices, post annual sales of nearly $5 billion and are fully-integrated operating companies encompassing strategy, innovation, prototyping, clinical trials, sales, marketing, manufacturing, distribution, and business development and, employ more than 8,000 associates around the world.

Ashley’s varied career that spans more than 20 years at J&J has given her a combination of health care, medical device and brand building savvy that make her particularly suited to size up and respond to the challenges inherent in running these hybrid businesses. Ashley’s accomplishments have been recognized by numerous business and philanthropic organizations and she was named a “2012 Working Mother of the Year” by Working Mother Magazine.

Do You Have

A STORY TO TELL?

If you’d like to be considered as a guest on a future episode of the Medtech Talk Podcast, please complete the application today.

Meet Our Host

Geoff Pardo

Geoff-Pardo

Geoff has been in medtech for over two decades in both operational and investment roles. He is passionate about the industry potential and sharing stories from the front lines of innovation.

Subscribe

ON iTUNES

Don't miss an episode. Join the conversation by visiting our podcast channel on iTunes today and subscribe. It's fast and free!